Description: Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities.
Home Page: orionbiotechopportunities.com
ORIA Technical Analysis
One Vanderbilt Avenue
New York,
NY
10017
United States
Phone:
212 303 1650
Officers
| Name | Title |
|---|---|
| Mr. Zuie-Chin Huang M.B.A. | CEO & Director |
| Mr. Mark Kayal | CFO & Sec. |
| Mr. Robert Kenneth Simonds | Gen. Counsel, Assistant Sec., VP & Director |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 62.2222 |
| Price-to-Book MRQ: | 1.2919 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-07-13 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |